PIL error: Orifarm Concerta XL

MHRA has issued a class four alert relating to a PIL error in Orifarm parallel import packs of Concerta XL 18mg and 36mg prolonged release tablets (methylphenidate hydrochloride).

See affected batches

The error relates to information on the side effects which is incorrectly included in paragraph 3 instead of paragraph 4. The quality of the medicine is not affected and no action is necessary.

For medical information and stock control queries please email jacook@Orifarm.com, or telephone 01923 204333.

MHRA alert

Latest news

England & Wales: Sixth September concession price update

The Department of Health and Social Care has published a sixth update to the initial list of September concessions. This update adds 17 prices. This brings the total number of September concessions to 181. The changes (in bold) are detailed i

Wales opens SLS consultation

Draft proposals look to lift Selected List Scheme (SLS) restrictions in Wales. A new consultation, open until December 17, proposes to remove a number of restrictions that no longer appear necessary or proportionate, including restrictions relating

DHSC pledges consideration of rural issues in Carr-Hill formula review

Recommendations for review of the Carr-Hill formula are with the Department for consideration, including how to target resources more effectively, pharmacy minister Dame Diana Johnson has said. In a written answer to Central Suffolk and North Ipswic

PIL error: Orifarm Concerta XL

Latest news

England & Wales: Sixth September concession price update

Wales opens SLS consultation

DHSC pledges consideration of rural issues in Carr-Hill formula review

View all news

DDA Suppliers Directory

MediP

Dispensing Doctor Experts

Follow us

Dispensing Doctors' Association

DDA Best Practice Group

Dispensing Doctors' Association